Nmur1-/- mice are not protected from cutaneous inflammation

被引:8
作者
Abbondanzo, Susan J. [1 ]
Manfra, Denise J. [2 ]
Chen, Shu-Cheng [2 ]
Pinzon-Ortiz, Maria [2 ]
Sun, Yongliang [2 ]
Phillips, Jonathan E. [3 ]
Laverty, Maureen [1 ]
Vassileva, Galya [1 ]
Hu, Weiwen [1 ]
Yang, Shijun [1 ]
Gustafson, Eric L. [1 ]
Fine, Jay S. [2 ]
Hedrick, Joseph A. [1 ]
机构
[1] Schering Plough Res Inst, Dept Discovery Technol, Kenilworth, NJ 07033 USA
[2] Schering Plough Res Inst, Dept Inflammat, Kenilworth, NJ 07033 USA
[3] Schering Plough Res Inst, Dept Pulm & Peripheral Neurobiol, Kenilworth, NJ 07033 USA
关键词
Neuromedin U receptor 1; Inflammation; CFA; Mice; Knockout; NEUROMEDIN-U RECEPTORS; MAST-CELLS; EXPRESSION; IDENTIFICATION; RAT; ACTIVATION; RESPONSES; PATHWAY; OBESITY; SYSTEM;
D O I
10.1016/j.bbrc.2008.11.148
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Neuromedin U (Nmu) is a neuropeptide expressed primarily in the gastrointestinal tract and central nervous system. Previous reports have identified two G protein-Coupled receptors (designated Nmur1 and Nmur2) that bind Nmu. Recent reports suggest that Nmu mediates immune responses involving mast cells, and Nmur1 has been proposed to mediate these responses. In this study, we generated mice with an Nmur1 deletion and then profiled the responses of these mice in a cutaneous inflammation model Utilizing complete Freund's adjuvant (CFA). We report here that mice lacking Nmur1 had normal inflammation responses with moderate changes in serum cytokines compared to Nmur1(-/-) littermates. Although differences in IL-6 were observed in mice lacking Nmu peptide, these mice exhibited a normal response to CFA. Our data argues against a major role for Nmur1 in mediating the reported inflammatory functions of NmU. (C) 2008 Elsevier Inc. All rights reserved.
引用
收藏
页码:777 / 782
页数:6
相关论文
共 24 条
[1]  
BOZIC CR, 1995, J IMMUNOL, V154, P6048
[2]   Neuromedin U and its receptors: Structure, function, and physiological roles [J].
Brighton, PJ ;
Szekeres, PG ;
Willars, GB .
PHARMACOLOGICAL REVIEWS, 2004, 56 (02) :231-248
[3]   Neuromedin U can exert colon-specific, enteric nerve-mediated prokinetic activity, via a pathway involving NMU1 receptor activation [J].
Dass, N. B. ;
Bassil, A. K. ;
North-Laidler, V. J. ;
Morrow, R. ;
Aziz, E. ;
Tuladhar, B. R. ;
Sanger, G. J. .
BRITISH JOURNAL OF PHARMACOLOGY, 2007, 150 (04) :502-508
[4]   Neuromedin U - a new target in obesity [J].
Doggrell, SA .
EXPERT OPINION ON THERAPEUTIC TARGETS, 2005, 9 (04) :875-877
[5]   Cloning and characterization of murine neuromedin U receptors [J].
Funes, S ;
Hedrick, JA ;
Yang, SJ ;
Shan, LX ;
Bayne, M ;
Monsma, FJ ;
Gustafson, EL .
PEPTIDES, 2002, 23 (09) :1607-1615
[6]   Association between neuromedin U gene variants and overweight and obesity [J].
Hainerova, Irena ;
Torekov, Signe S. ;
Ek, Jakob ;
Finkova, Marie ;
Borch-Johnsen, Knut ;
Jorgensen, Torben ;
Madsen, Ole D. ;
Lebl, Jan ;
Hansen, Torben ;
Pedersen, Oluf .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2006, 91 (12) :5057-5063
[7]   Neuromedin U has a novel anorexigenic effect independent of the leptin signaling pathway [J].
Hanada, R ;
Teranishi, H ;
Pearson, JT ;
Kurokawa, M ;
Hosoda, H ;
Fukushima, N ;
Fukue, Y ;
Serino, R ;
Fujihara, H ;
Ueta, Y ;
Ikawa, M ;
Okabe, M ;
Murakami, N ;
Shirai, M ;
Yoshimatsu, H ;
Kangawa, K ;
Kojima, M .
NATURE MEDICINE, 2004, 10 (10) :1067-1073
[8]   Identification of a human gastrointestinal tract and immune system receptor for the peptide neuromedin U [J].
Hedrick, JA ;
Morse, K ;
Shan, LX ;
Qiao, XD ;
Pang, L ;
Wang, S ;
Laz, T ;
Gustafson, EL ;
Bayne, M ;
Monsma, FJ .
MOLECULAR PHARMACOLOGY, 2000, 58 (04) :870-875
[9]   Neuromedin U elicits cytokine release in murine Th2-type T cell clone D10.G4.1 [J].
Johnson, EN ;
Appelbaum, ER ;
Carptenter, DC ;
Cox, RF ;
Disa, J ;
Foley, JJ ;
Ghosh, SK ;
Naselsky, DP ;
Pullen, MA ;
Sarau, HM ;
Scheff, SR ;
Steplewski, KM ;
Zaks-Zilberman, M ;
Aiyar, N .
JOURNAL OF IMMUNOLOGY, 2004, 173 (12) :7230-7238
[10]  
Kaczmarek P, 2006, INT J MOL MED, V18, P951